These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 7578434)
21. ADP-ribosylated proteins as old and new drug targets for anticancer therapy: the example of ARF6. Dani N; Barbosa AJ; Del Rio A; Di Girolamo M Curr Pharm Des; 2013; 19(4):624-33. PubMed ID: 23016858 [TBL] [Abstract][Full Text] [Related]
22. [Metabolism and cellular functions of poly(ADP-ribose)]. Miwa M; Masutani M Seikagaku; 2006 Nov; 78(11):1050-61. PubMed ID: 17176893 [No Abstract] [Full Text] [Related]
23. Differentiation of 3T3-L1 pre-adipocytes induced by inhibitors of poly(ADP-ribose) polymerase and by related noninhibitory acids. Janssen OE; Hilz H Eur J Biochem; 1989 Apr; 180(3):595-602. PubMed ID: 2523799 [TBL] [Abstract][Full Text] [Related]
25. Direct stimulation of poly(ADP ribose) polymerase in permeabilized cells by double-stranded DNA oligomers. Grube K; Küpper JH; Bürkle A Anal Biochem; 1991 Mar; 193(2):236-9. PubMed ID: 1908195 [TBL] [Abstract][Full Text] [Related]
26. Progress in the function and regulation of ADP-Ribosylation. Hottiger MO; Boothby M; Koch-Nolte F; Lüscher B; Martin NM; Plummer R; Wang ZQ; Ziegler M Sci Signal; 2011 May; 4(174):mr5. PubMed ID: 21610250 [TBL] [Abstract][Full Text] [Related]
27. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro. Lin KY; Huang D; Kraus WL Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863 [TBL] [Abstract][Full Text] [Related]
28. Studying Catabolism of Protein ADP-Ribosylation. Palazzo L; James DI; Waddell ID; Ahel I Methods Mol Biol; 2017; 1608():415-430. PubMed ID: 28695524 [TBL] [Abstract][Full Text] [Related]
29. Structure, Function and Inhibition of Poly(ADP-ribose)polymerase, Member 14 (PARP14). Schweiker SS; Tauber AL; Sherry ME; Levonis SM Mini Rev Med Chem; 2018; 18(19):1659-1669. PubMed ID: 30112992 [TBL] [Abstract][Full Text] [Related]
31. Poly(ADP-ribose). The most elaborate metabolite of NAD+. Bürkle A FEBS J; 2005 Sep; 272(18):4576-89. PubMed ID: 16156780 [TBL] [Abstract][Full Text] [Related]
32. Regulation of nucleocytoplasmic transport by ADP-ribosylation: the emerging role of karyopherin-β1 mono-ADP-ribosylation by ARTD15. Di Girolamo M Curr Top Microbiol Immunol; 2015; 384():189-209. PubMed ID: 25037261 [TBL] [Abstract][Full Text] [Related]
37. Acceptors for the poly ADP-ribosylation modification of chromatin structure are altered by carcinogen-induced DNA damage. Thraves PJ; Smulson ME Carcinogenesis; 1982; 3(10):1143-8. PubMed ID: 6293734 [TBL] [Abstract][Full Text] [Related]
38. Detecting and Quantifying pADPr In Vivo. Lai YC; Aneja RK; Satchell MA; Clark RSB Methods Mol Biol; 2017; 1608():27-43. PubMed ID: 28695501 [TBL] [Abstract][Full Text] [Related]
39. Novel alkoxybenzamide inhibitors of poly(ADP-ribose) polymerase. Menear KA; Adcock C; Alonso FC; Blackburn K; Copsey L; Drzewiecki J; Fundo A; Le Gall A; Gomez S; Javaid H; Lence CF; Martin NM; Mydlowski C; Smith GC Bioorg Med Chem Lett; 2008 Jul; 18(14):3942-5. PubMed ID: 18579376 [TBL] [Abstract][Full Text] [Related]
40. The emerging role of poly(ADP-ribose) polymerase-1 in longevity. Bürkle A; Brabeck C; Diefenbach J; Beneke S Int J Biochem Cell Biol; 2005 May; 37(5):1043-53. PubMed ID: 15743677 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]